These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11860346)

  • 1. The cellular electrophysiologic effect of a new amiodarone like antiarrhythmic drug GYKI 16638 in undiseased human ventricular muscle: comparison with sotalol and mexiletine.
    Opincariu M; Varró A; Iost N; Virág L; Hála O; Szolnoki J; Szécsi J; Bogáts G; Szenohradszky P; Mátyus P; Papp JG
    Curr Med Chem; 2002 Jan; 9(1):41-6. PubMed ID: 11860346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
    Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG
    Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of GYKI-23 107, a new antiarrhythmic compound, in isolated rabbit and canine cardiac preparations.
    Varró A; Németh M; Rabloczky G; Papp JG; Szekeres L
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):251-7. PubMed ID: 2452917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
    Kovács A; Gyönös I; Magyar J; Bányász T; Nánási PP; Spedding M; Szénási G
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antiarrhythmic compounds with combined class IB and class III mode of action.
    Mátyus P; Varga I; Rettegi T; Simay A; Kállay N; Károlyházy L; Kocsis A; Varró A; Pénzes I; Papp JG
    Curr Med Chem; 2004 Jan; 11(1):61-9. PubMed ID: 14754426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle.
    Marschang H; Beyer T; Karolyi L; Kübler W; Brachmann J
    Cardiovasc Drugs Ther; 1998 Dec; 12(6):573-83. PubMed ID: 10410827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle.
    Yang T; Tande PM; Refsum H
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):889-94. PubMed ID: 1282590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation.
    Hoffmeister HM; Beyer ME; Seipel L
    Am J Cardiol; 1997 Oct; 80(8A):24G-30G. PubMed ID: 9354409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
    Merot J; Charpentier F; Poirier JM; Coutris G; Weissenburger J
    Cardiovasc Res; 1999 Nov; 44(2):303-14. PubMed ID: 10690307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. I. Alteration of mexiletine-induced Vmax depression.
    Berman ND; Wang LY; Ahmed A
    Can J Cardiol; 1990 Nov; 6(9):416-22. PubMed ID: 2177359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.
    Baláti B; Iost N; Simon J; Varró A; Papp JG
    Gen Pharmacol; 2000 Feb; 34(2):85-93. PubMed ID: 10974415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Electrophysiologic Effects of Chronically Administered Amiodarone on Canine Purkinje Fibers versus Ventricular Muscle.
    Papp JG; Németh M; Krassói I; Mester L; Hála O; Varró A
    J Cardiovasc Pharmacol Ther; 1996 Oct; 1(4):287-296. PubMed ID: 10684429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.
    Varro A; Baláti B; Iost N; Takács J; Virág L; Lathrop DA; Csaba L; Tálosi L; Papp JG
    J Physiol; 2000 Feb; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness.
    Berman ND; Wang LY; Ahmed A
    Can J Cardiol; 1990 Nov; 6(9):423-30. PubMed ID: 2177360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium.
    Hézső T; Naveed M; Dienes C; Kiss D; Prorok J; Árpádffy-Lovas T; Varga R; Fujii E; Mercan T; Topal L; Kistamás K; Szentandrássy N; Almássy J; Jost N; Magyar J; Bányász T; Baczkó I; Varró A; Nánási PP; Virág L; Horváth B
    Sci Rep; 2021 May; 11(1):9565. PubMed ID: 33953276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sotalol and mexiletine: combination of rate-dependent electrophysiological effects.
    Varró A; Lathrop DA
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):557-67. PubMed ID: 1706796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium.
    Tande PM; Bjørnstad H; Yang T; Refsum H
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):401-10. PubMed ID: 1700210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.